2026 ICD-10-CM Diagnosis Code T38.6X1APoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter

ICD-10-CM Codes›S00–T88›T36-T50›T38

ICD-10-CM T38.6X1A
CMSSource: CMS FY 2026 ICD-10-CM dataset · Effective Oct 1, 2025 – Sep 30, 2026

T38.6X1A is a billable ICD-10-CM diagnosis code for poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter. The 7th character A marks it as an initial encounter code, used while the patient is receiving active treatment. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 917 through 918. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under External cause codes: intent of injury, accidental/unintentional; External cause codes: poisoning by drug; and Poisoning by drugs, initial encounter.

Code Identity

ICD-10-CM Code
T38.6X1A
Billable Status
Yes — Valid for Submission
Code Describes
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter
Short Description
Poisoning by antigonadtr/antiestr/antiandrg, NEC, acc, init
Parent Code
T38.6X1
Poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional)

Code Classification

ChapterS00–T88Injury, poisoning and certain other consequences of external causes
SectionT36-T50Poisoning by, adverse effect of and underdosing of drugs, medicaments and biological substances
CategoryT38Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified
This CodeT38.6X1APoisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter

Approximate SynonymsGuidance

Alternate terms and clinical phrases that map to this code.

  • Accidental formestane overdose
  • Accidental formestane poisoning
  • Accidental poisoning caused by corticosteroid and/or corticosteroid derivative
  • Accidental tamoxifen overdose
  • Accidental tamoxifen poisoning
  • Estrogen antagonist overdose
  • Estrogen antagonist poisoning
  • Formestane overdose
  • Formestane poisoning
  • Tamoxifen overdose
  • Tamoxifen poisoning

Coding GuidelinesGuidance

When coding a poisoning or reaction to the improper use of a medication (e.g., overdose, wrong substance given or taken in error, wrong route of administration), first assign the appropriate code from categories T36-T50. The poisoning codes have an associated intent as their 5th or 6th character (accidental, intentional self-harm, assault and undetermined). If the intent of the poisoning is unknown or unspecified, code the intent as accidental intent. The undetermined intent is only for use if the documentation in the record specifies that the intent cannot be determined. Use additional code(s) for all manifestations of poisonings.

The appropriate 7th character is to be added to each code from block Poisoning by, adverse effect of and underdosing of hormones and their synthetic substitutes and antagonists, not elsewhere classified (T38). Use the following options for the applicable episode of care:

  • A - initial encounter
  • D - subsequent encounter
  • S - sequela

Source: ICD-10-CM Official Guidelines for Coding and Reporting, FY 2026, published by CMS and the National Center for Health Statistics.

Clinical ClassificationClinical

AHRQ’s CCSR groups this code into broader clinical categories.

CCSR EXT020
External cause codes: intent of injury, accidental/unintentional
Default principal diagnosis: inpatient No · outpatient No
CCSR EXT014
External cause codes: poisoning by drug
Default principal diagnosis: inpatient No · outpatient No
CCSR INJ022
Poisoning by drugs, initial encounter
Default principal diagnosis: inpatient Yes · outpatient Yes

Clinical InformationClinical

  • Cyproterone

    an anti-androgen that, in the form of its acetate (cyproterone acetate), also has progestational properties. it is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.

  • Cyproterone Acetate

    an agent with anti-androgen and progestational properties. it shows competitive binding with dihydrotestosterone at androgen receptor sites.

  • Danazol

    a synthetic steroid with antigonadotropic and anti-estrogenic activities that acts as an anterior pituitary suppressant by inhibiting the pituitary output of gonadotropins. it possesses some androgenic properties. danazol has been used in the treatment of endometriosis and some benign breast disorders.

  • Flutamide

    an antiandrogen with about the same potency as cyproterone in rodent and canine species.

  • Mifepristone

    a progestational and glucocorticoid hormone antagonist. its inhibition of progesterone induces bleeding during the luteal phase and in early pregnancy by releasing endogenous prostaglandins from the endometrium or decidua. as a glucocorticoid receptor antagonist, the drug has been used to treat hypercortisolism in patients with nonpituitary cushing syndrome.

  • Nafoxidine

    an estrogen antagonist that has been used in the treatment of breast cancer.

  • Tamoxifen

    one of the selective estrogen receptor modulators with tissue-specific activities. tamoxifen acts as an anti-estrogen (inhibiting agent) in the mammary tissue, but as an estrogen (stimulating agent) in cholesterol metabolism, bone density, and cell proliferation in the endometrium.

  • Toremifene

    a first generation selective estrogen receptor modulator (serm). like tamoxifen, it is an estrogen agonist for bone tissue and cholesterol metabolism but is antagonistic on mammary and uterine tissue.

Table of Drugs and ChemicalsClinical

Substances in the Table of Drugs and Chemicals that reference this code family. Always confirm in the Tabular List before coding.

SubstanceAccidentalSelf-harmAssaultUndeter­minedAdverse
Effect		Under­dosing
Antiandrogen NECT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
Antiestrogen NECT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
Antigonadotrophin NECT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
CyproteroneT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
DanazolT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
FlutamideT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
MifepristoneT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
NafoxidineT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
NilutamideT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
OrmeloxifeneT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
TaleranolT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
TamoxifenT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6
ToremifeneT38.6X1T38.6X2T38.6X3T38.6X4T38.6X5T38.6X6

Patient EducationClinical

Medication Errors

Medicines treat infectious diseases, prevent problems from chronic diseases, and ease pain. But medicines can also cause harmful reactions if not used correctly. Errors can happen in the hospital, at the health care provider's office, at the pharmacy, or at home. You can help prevent errors by:

Read the full article at MedlinePlus

Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.

Convert T38.6X1A to ICD-9-CMHistory

The closest ICD-9-CM equivalents under the General Equivalence Mappings.

ICD-9-CM
962.1 Poisoning-androgens
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.
ICD-9-CM
E858.0 Acc poison-hormones
ApproximateCombination The match is approximate, and more than one code can be needed to describe the source diagnosis. Confirm with contextual judgment.

Code HistoryHistory

FY 2016AddedAdded to the ICD-10-CM code setEffective October 1, 2015, the first year of ICD-10-CM.
FY 2017–2025No changes
FY 2026CurrentCurrent code set, no changesEffective October 1, 2025 through September 30, 2026.

Questions About T38.6X1AOverview

Is T38.6X1A a billable code?

Yes. This is a billable ICD-10-CM code, specific enough to report poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter on HIPAA-covered claims from October 1, 2025 through September 30, 2026.

What does the 7th character A in T38.6X1A mean?

The final character A marks the initial encounter: use it while the patient is receiving active treatment for poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), such as an emergency visit or first evaluation.

What MS-DRG does T38.6X1A group to?

When poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter is the principal diagnosis on an inpatient stay, it groups to MS-DRG 917, 918, with relative weights from 0.8571 to 1.5684 depending on complications. Higher weights mean higher Medicare reimbursement.

What is the ICD-9 equivalent of T38.6X1A?

Under the General Equivalence Mappings, poisoning by antigonadotrophins, antiestrogens, antiandrogens, not elsewhere classified, accidental (unintentional), initial encounter converts to ICD-9-CM 962.1 (poisoning-androgens) and E858.0 (acc poison-hormones). The mapping is approximate, so confirm the match fits the documentation.

Footnotes

[1] Not chronic - A diagnosis code that does not fit the criteria for chronic condition (duration, ongoing medical treatment, and limitations) is considered not chronic. Some codes designated as not chronic are acute conditions. Other diagnosis codes that indicate a possible chronic condition, but for which the duration of the illness is not specified in the code description (i.e., we do not know the condition has lasted 12 months or longer) also are considered not chronic.